DBM is a member of two New Zealand government committees relevant to drug therapy and has participated in the International Society of Drug Bulletins (ISDB). The authors have no other competing interests to explain. The opinions expressed in this article are their own and not those of an organization to which they are linked. Has. The Agency releases the Advertiser from any claim, loss, action, liability or judgment of the Advertiser, including reasonable attorneys` fees and expenses, based on or related to any article established by the Agency or at the direction of the Agency, including, but not limited to, claims for defamation, defamation, piracy, plagiarism, violation of privacy, or in violation of copyright or other intellectual property interests, unless such a claim results from material provided by the Advertiser and incorporated into materials or advertisements established by the Agency. .